Sam Brusco, Associate Editor11.14.23
Biocoat, a specialty manufacturer of hydrophilic biomaterial coatings and coating equipment for medical devices, has named Scott D’Amour as its new chief financial officer (CFO). D’Amour replaces the retiring Steve Bell, who’s held the position since 2019.
D’Amour boasts over 15 years of experience in the industry. He’s served in financial leadership positions at Leidos, Berkshire Grey, Medtronic, HeartWare, Biotage, Bioprocessors, and Applied Biosystems.
"Steve has led all financial dealings for two different private equity transactions and was an integral part of Biocoat's growth over the last five years. We cannot thank Steve enough for the dedication and expertise he has provided our organization, and we wish Steve the best in his retirement," Biocoat president and CEO Jim Moran told the press. "As the transition plan continues, we welcome Scott D'Amour to the Executive Team. We are excited to put Scott's broad experience into action as we further expand Biocoat's full-service offering in the medical device industry".
"I am excited to join Biocoat at a time when the company is experiencing growth and is focused on expanding into the biomaterials market. I look forward to joining an amazing team that is dedicated to the continued growth of the organization," added D'Amour.
D’Amour boasts over 15 years of experience in the industry. He’s served in financial leadership positions at Leidos, Berkshire Grey, Medtronic, HeartWare, Biotage, Bioprocessors, and Applied Biosystems.
"Steve has led all financial dealings for two different private equity transactions and was an integral part of Biocoat's growth over the last five years. We cannot thank Steve enough for the dedication and expertise he has provided our organization, and we wish Steve the best in his retirement," Biocoat president and CEO Jim Moran told the press. "As the transition plan continues, we welcome Scott D'Amour to the Executive Team. We are excited to put Scott's broad experience into action as we further expand Biocoat's full-service offering in the medical device industry".
"I am excited to join Biocoat at a time when the company is experiencing growth and is focused on expanding into the biomaterials market. I look forward to joining an amazing team that is dedicated to the continued growth of the organization," added D'Amour.